AMZN
Amazon.com, Inc.
AMZN has the edge over MBC overall, supported by stronger valuation and lower modeled downside.
MBC
MasterBrand, Inc.
MBC trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MBC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
MBC's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
MBC PE Valuation
MBC has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over MBC on the outlook, with more favorable earnings and profitability expectations.
MBC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect MBC's revenue to grow, but its earnings and profitability to decline.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MBC on earnings quality, reporting a profit while its opponent remains loss making.
MBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.87 | -238% |
| Q2 2026 | -$0.68 | -196% |
| Q1 2026 | -$0.01 | -101% |
| Q4 2025 | $0.21 | -78% |
| Q3 2025 | $0.63 | -45% |
| Q2 2025 | $0.71 | -49% |
| Q1 2025 | $0.77 | -46% |
| Q4 2024 | $0.96 | -31% |
MBC has swung to a loss: it lost $0.87 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MBC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MBC on profitability, with a higher operating margin.
MBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1B | +48% |
| Q2 2026 | $815.2M | +12% |
| Q1 2026 | $618M | -6.4% |
| Q4 2025 | $644.6M | -3.5% |
| Q3 2025 | $698.9M | -2.7% |
| Q2 2025 | $730.9M | +8% |
| Q1 2025 | $660.3M | +3.5% |
| Q4 2024 | $667.7M | -1.4% |
MBC's revenue has picked up after two years of holding roughly level: $1B last quarter, up 48% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1% | -5 points |
| Q2 2026 | -3.4% | -13 points |
| Q1 2026 | -3% | -8.6 points |
| Q4 2025 | -4.2% | -9.8 points |
| Q3 2025 | 6% | -2 points |
| Q2 2025 | 9.2% | -2.3 points |
| Q1 2025 | 5.6% | -4.2 points |
| Q4 2024 | 5.6% | -3.4 points |
MBC's operating margin was 1% last quarter, down 5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.2M | +55% |
| Q2 2026 | $128.6M | +93% |
| Q1 2026 | -$146.2M | -$105M |
| Q4 2025 | $52.5M | -24% |
| Q3 2025 | $39.5M | -39% |
| Q2 2025 | $66.7M | +0.9% |
| Q1 2025 | -$41.2M | -452% |
| Q4 2024 | $68.8M | +107% |
MBC has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over MBC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +49.9M shares |
| 1 year | +57% | +74M shares |
| 3 years | +56% | +73.2M shares |
| 5 years | +59% | +75.5M shares |
MBC has 204M diluted shares, up 57% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $6.7M |
| Q1 2025 | $11.4M |
| Q4 2024 | — |
MBC hasn't bought back shares in the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over MBC on leverage, with a lower net debt burden relative to earnings.
MBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 12.7x | High |
| Q2 2026 | 13.4x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.0x | Elevated |
| Q2 2025 | 3.0x | Elevated |
| Q1 2025 | 3.2x | Elevated |
| Q4 2024 | 2.8x | Moderate |
MBC's net debt is about 13 years of its operating earnings (EBITDA), up from 3.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 16.4 | Oversold |
MBC's weekly RSI is 35 (neutral) and its Stochastic is 16 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MBC PE vs Consumer Cyclical Sector
| Metric | MBC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
MBC has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MBC on trend strength, trading above more of its moving averages.
MBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.89 | 10% below |
| 20 week MA | $7.91 | 22% below |
| 50 week MA | $9.12 | 32% below |
| 100 week MA | $10.9 | 43% below |
| 200 week MA | $12.4 | 50% below |
MBC is in a downtrend: it's below all five of its weekly moving averages, and 50% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over MBC on returns for 2026, with the stronger performance.
MBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $10.0 | $7.58 | -24% |
| 2023 | $7.58 | $14.9 | +96% |
| 2024 | $14.9 | $14.4 | -2.8% |
| 2025 | $14.4 | $11.3 | -22% |
| 2026 YTD | $11.3 | $6.19 | -45% |
MBC has finished lower in three of the last four years. It's down 45% so far in 2026.